Medical technology manufacturer plans to divest diabetes products business / Focus on injection systems © 2001-2024 Plasteurope.com | Imprint | Privacy | Cookie settings ...

Switzerland is scrambling to keep a lid on immigration from its top trade partner, the European Union, as a jobs boom powered ...

Switzerland is scrambling to keep a lid on immigration from its top trade partner, the European Union, as a jobs boom powered ...

Advancements in medical technology and increasing awareness about diabetes and blood testing drive innovation and adoption in the lancet industry.

The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...

Generating thousands of dollars of recurring income can be a great way to make you less reliant on employment income or ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Novo Nordisk's (NVO) contract Ypsomed to supply the company with injection pens designed to deliver its next-gen obesity ...

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...

The Jefferies London Healthcare Conference at Waldorf Hilton drew thousands, focusing heavily on GLP-1 manufacturing. Notable ...

Injection Pen Market. The global injection pen market is on track for substantial growth, with a forecasted compound annual ...

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Ypsomed Holding, this is the ...